Stock comparison
Galapagos N.V.
Eli Lilly
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
GLPG
Galapagos N.V.
Market cap
$1.81B
Sector
Healthcare
LLY
Eli Lilly
Market cap
$1T
Sector
Healthcare
Overall winner
Eli Lilly LLY
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | GLPG | LLY | Winner |
|---|---|---|---|
| Warren Buffett | 41D | 72B | LLY |
| Benjamin Graham | 28F | 86A | LLY |
| Philip Fisher | 56C | 86A | LLY |
| Peter Lynch | 76B | 74B | GLPG |
| Joel Greenblatt | 39D | 78C | LLY |
| Charlie Munger | 46D | 85A | LLY |
| Terry Smith | 46D | 77C | LLY |
Side-by-side metrics
| Metric | GLPG | LLY |
|---|---|---|
| Market cap | $1.81B | $1T |
| P/E (TTM) | 3.1x | 36.6x |
| EV/EBIT | 2.9x | 34.1x |
| ROIC (TTM) | 17.67% | 32.06% |
| Gross margin | 98.01% | 83.51% |
| Net margin | 46.83% | 34.98% |
| Revenue CAGR 5y | 23.07% | 23.17% |
| EPS CAGR 5y | - | 40.81% |
| Debt / Equity | 0.0x | 1.4x |
| Dividend yield | 0.0% | 0.62% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
GLPG leads on
- Debt / Equity0.0xvs 1.4x+100%
- P/E (TTM)3.1xvs 36.6x+92%
- EV/EBIT2.9xvs 34.1x+92%
- Net margin46.83%vs 34.98%+25%
LLY leads on
- Dividend yield0.62%vs 0.0%+100%
- Market cap$1Tvs $1.81B+100%
- ROIC (TTM)32.06%vs 17.67%+45%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.